COMPARISON OF PSORIATIC ARTHRITIS THERAPEUTIC TARGETS - PSA-MDA AND DAPSA REMISSION/LOW DISEASE ACTIVITY IN PATIENTS TREATED IN THE INSTITUTE OF RHEUMATOLOGY PRAGUE

被引：0
|
作者：
Stolfa, J. [1 ,2 ]
Sedova, L. [1 ,2 ]
Mares, Z. [1 ]
机构：
[1] Charles Univ Prague, Med Fac 1, Inst Rheumatol, Prague, Czech Republic
[2] Charles Univ Prague, Med Fac 1, Clin Rheumatol, Prague, Czech Republic
来源：
ANNALS OF THE RHEUMATIC DISEASES | 2018年 / 77卷
关键词：
D O I：
10.1136/annrheumdis-2018-eular.6194
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
AB0925
引用
收藏
页码：1587 / 1588
页数：2
相关论文
共 50 条
  • [1] APPLICATION OF DISEASE ACTIVITY INDEX FOR PSORIATIC ARTHRITIS (DAPSA) IN A COHORT OF PATIENTS FOLLOWED IN THE INSTITUTE OF RHEUMATOLOGY PRAGUE
    Stolfa, J.
    Sedova, L.
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2016, 75 : 813 - 813
  • [2] DEFINING THE THERAPEUTIC TARGET IN PSORIATIC ARTHRITIS: ASSOCIATION BETWEEN MINIMAL DISEASE ACTIVITY (MDA) AND DISEASE ACTIVITY IN PSORIATIC ARTHRITIS (DAPSA)
    Coronel Ale, A. L.
    Cerda, O. L.
    Fornaro, M. N.
    Isnardi, C. A.
    Schneeberger, E. E.
    Citera, G.
    [J]. JCR-JOURNAL OF CLINICAL RHEUMATOLOGY, 2018, 24 : S117 - S118
  • [3] ACHIEVEMENT OF PASDAS LOW DISEASE ACTIVITY AND VERY LOW DISEASE ACTIVITY IN PATIENTS WITH PSORIATIC ARTHRITIS TREATED WITH CERTOLIZUMAB PEGOL OVER 4 YEARS AND THE OVERLAP WITH DAPSA AND MDA DISEASE ACTIVITY TARGETS
    Coates, Laura C.
    Merola, Joseph F.
    Fitzgerald, Oliver
    Kavanaugh, Arthur
    Gottlieb, Alice B.
    Tillett, William
    Bauer, Lars
    Hoepken, Bengt
    Nurminen, Tommi
    Mease, Philip J.
    Helliwell, Philip
    van der Heijde, Desiree
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2019, 78 : 1836 - 1837
  • [4] Disease activity in psoriatic arthritis (PsA): defining remission and treatment success using the DAPSA score
    Schoels, Monika M.
    Aletaha, Daniel
    Alasti, Farideh
    Smolen, Josef S.
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2016, 75 (05) : 811 - 818
  • [5] DISEASE ACTIVITY IN PSORIATIC ARTHRITIS (PSA): DEFINING REMISSION AND TREATMENT SUCCESS USING THE DAPSA-SCORE
    Schoels, M.
    Aletaha, D.
    Alasti, F.
    Haslacher, H.
    Smolen, J.
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2015, 74 : 869 - 869
  • [6] Comparison of disease activity index for psoriatic arthritis (DAPSA) and minimal disease activity (MDA) targets for patients with psoriatic arthritis: A post hoc analysis of data from phase 3 tofacitinib studies
    Schneeberger, Emilce E.
    Citera, Gustavo
    Nash, Peter
    Smolen, Josef S.
    Mease, Philip J.
    Soriano, Enrique R.
    Helling, Claudia
    Szumski, Annette E.
    Mundayat, Rajiv
    de Leon, Dario Ponce
    [J]. SEMINARS IN ARTHRITIS AND RHEUMATISM, 2023, 58
  • [7] DAPSA REMISSION/LOW DISEASE ACTIVITY IS ASSOCIATED WITH LOW PSAID12 IN PSORIATIC ARTHRITIS
    Garcia-Porrua, C.
    Fernandez-Dominguez, L.
    Guerra-Vazquez, J. L.
    Mosquera Martinez, J. A.
    Pinto-Tasende, J.
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2020, 79 : 1679 - 1680
  • [8] Very Low Disease Activity, DAPSA Remission, and Impact of Disease in a Spanish Population with Psoriatic Arthritis
    Queiro, Ruben
    Canete, Juan D.
    Montilla, Carlos
    Angel Abad, Miguel
    Montoro, Maria
    Gomez, Susana
    Cabez, Ana
    Torre Alonso, J. C.
    Roman-Ivorra, J. A.
    Sanz, J.
    Salvatierra, J.
    Calvo-Alen, J.
    Sellas, A.
    Rodriguez, F. J.
    Bermudez, A.
    Romero, M.
    Riesco, M.
    Cobeta, J. C.
    Medina, F.
    Aragon, A.
    Garcia, M. L.
    Urruticoechea, A.
    Gonzalez, C. M.
    Judez, E.
    Gonzalez, B.
    Fernandez, P.
    Pantoja, L.
    Morla, R.
    [J]. JOURNAL OF RHEUMATOLOGY, 2019, 46 (07) : 710 - 715
  • [9] Validation of New Potential Targets for Remission and Low Disease Activity in Psoriatic Arthritis in Patients Treated with Golimumab
    Coates, Laura
    Rahman, Proton
    Psaradellis, Eliofotisti
    Rampakakis, Emmanouil
    Osborne, Brendan
    Lehman, Allen
    Nantel, Francois
    [J]. JOURNAL OF RHEUMATOLOGY, 2018, 45 (07) : 995 - 995
  • [10] Validation of new potential targets for remission and low disease activity in psoriatic arthritis in patients treated with golimumab
    Coates, Laura C.
    Rahman, Proton
    Psaradellis, Eliofotisti
    Rampakakis, Emmanouil
    Osborne, Brendan
    Lehman, Allen J.
    Nantel, Francois
    [J]. RHEUMATOLOGY, 2019, 58 (03) : 522 - 526
12345